Showing 1651-1660 of 1960 results for "".
- Sculptra Gets New Labelhttps://modernaesthetics.com/news/sculptra-gets-new-label/2473175/A new FDA-approved label for Sculptra® (injectable poly-L-lactic acid (PLLA)) from Galderma includes higher dilution, the addition of immediate use reconstitution, new injection techniques, and the optional addition of lidocaine. Sculptra is the first and only FDA-approved PLLA facial in
- Galderma to Acquire Alastin Skincarehttps://modernaesthetics.com/news/galderma-to-acquire-alastin-skincare/2473169/Galderma is set to acquire Alastin Skincare®, Inc. The world’s largest independent dermatology company has signed a definitive agreement to acquire the specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products. Financial
- NeoGenesis Products Expand Beyond Oncology Skin Carehttps://modernaesthetics.com/news/neogenesis-products-expand-beyond-oncology-skin-care/2473164/NeoGenesis’ science-based skin and hair products have expanded from oncology aftercare to management of chronic skin conditions, aesthetic concerns, and wound support. The products were developed to provide a safe, natural approach to improving the quality of life of those undergoing oncolo
- Gryphon Investors Signs Deal to Aquire Revision Skincarehttps://modernaesthetics.com/news/gryphon-investors-signs-deal-to-aquire-revision-skincare/2473163/The Middle-market private equity firm Gryphon Investors has signed a definitive agreement to acquire Revision Skincare and Goodier Cosmetics, with an anticipating closing date this year. Financial terms of the transaction were not disclosed. Revision Goodier's management team
- RoC Skincare: Sunday is National Retinol Dayhttps://modernaesthetics.com/news/roc-skincare-sunday-is-national-retinol-day/2473161/Sunday marks the first-ever National Retinol Day. As people around the country turn their clocks back for daylight savings on November 7, RoC® is bringing attention to the use of retinol to help turn back the clock on fine lines and wrinkles. National Retinol Day has been registered
- Meet the New Dermalogica Scholarship Winnershttps://modernaesthetics.com/news/meet-the-new-dermalogica-scholarship-winners/2473158/Dermalogica has awarded two New Beginnings scholarships to aesthetics students. Each scholarship recipient receives a $5,000 award and a professional development mentorship with a Dermalogica expert skin therapist. The New Beginnings scholarship is available to students enrolled i
- Alastin Launches Sensitive Skincare Collectionhttps://modernaesthetics.com/news/alastin-launches-sensitive-skincare-collection/2473154/Alastin’s new sensitive skin collection has launched with three sensitive skincare products: Ultra Calm Cleansing Cream, Ultra Light Moisturizer with TriHex Technology® and SilkSHIELD All-Mineral Sunscreen SPF 30 with TriHex Technology®. The collection includes ultra-calming, restor
- ASDSA Applauds FDA for Safety Communication on Needle-less Injector Deviceshttps://modernaesthetics.com/news/asdsa-applauds-fda-for-safety-communication-on-needle-less-injector-devices/2473151/The American Society for Dermatologic Surgery Association (ASDSA) applauds the U.S. Food and Drug Administration (FDA) for sending out a safety communication regarding needle-less devices, such as hyaluron p
- Cynosure Launches Potenza™ RF Microneedling System with New Fusion Tip™ in Canadahttps://modernaesthetics.com/news/cynosure-launches-potenza-rf-microneedling-system-with-new-fusion-tip-in-canada/2473149/Health Canada has cleared Cynosure’s Potenza™ radiofrequency (RF) microneedling system, offering clinicians versatility and personalized treatments for patients with the system's one-of-a-kind Fusion
- Alastin Receives Two New Patents for Technology Related to TransFORM Body Treatmenthttps://modernaesthetics.com/news/alastin-receives-two-new-patents-for-technology-related-to-transform-body-treatment/2473148/With the issuance of two new patents from the United States Patent and Trademark Office, Alastin Skincare, Inc. now holds six patents in the US, along with a seventh patent issued in Canada. US Patent No.11,052,032 covers Alastin’s